RSS

Gene therapies

European Pharmaceutical Manufacturer examines some of the biggest trends that have taken place throughout 2019. Read more

Opinion

The Centre for Process Innovation (CPI) has announced it has overcome a significant bottleneck in the development of gene therapies. Read more

News

Clive Glover, strategy director and cell and gene therapy lead at Pall Corporation, explains why we need to take a more holistic approach to gene therapy manufacturing processes. Read more

Opinion

Contract drug manufacturer Catalent has completed its $1.2 billion acquisition of gene therapy manufacturer Paragon Bioservices, the company has announced. Read more

News